Sustained Antihypertensive Effect of Captopril Combined with Diuretics and Beta‐adrenergic Blocking Drugs in Patients with Resistant Hypertension
- 12 January 1983
- journal article
- research article
- Published by Wiley in Acta Medica Scandinavica
- Vol. 213 (4) , 299-303
- https://doi.org/10.1111/j.0954-6820.1983.tb03738.x
Abstract
Ten patients with severe hypertension and unsatisfactory blood pressure control during combined therapy with .beta.-adrenergic blocking drugs, diuretics and vasodilators were treated with gradually increasing doses of captopril. Vasodilators were discontinued 24 h prior to captopril administration. Six patients had essential, 2 renal and 2 renovascular hypertension. Mild renal impairment was observed in 4 patients. Captopril effectively decreased blood pressure for 3 h in all patients after the 1st dose. The antihypertensive effect appeared to be triphasic and was sustained in all but 1 patient during 12 mo. of observation. Captopril doses of 25-75 mg t.i.d. [3 times/day) were sufficient to achieve acceptable blood pressure control (RR .ltoreq. 160/100 mm Hg) when given in this mentioned combination. Side-effects were few and tolerable and discontinuation of captopril was not required.This publication has 15 references indexed in Scilit:
- Acute and chronic treatment of severe and malignant hypertension with the oral angiotensin-converting enzyme inhibitor captopril.Circulation, 1981
- CAPTOPRIL AND FRUSEMIDE IN SEVERE DRUG-RESISTANT HYPERTENSIONThe Lancet, 1980
- Captopril compared with other antirenin system agents in hypertensive patients: its triphasic effects on blood pressure and its use to identify and treat the renin factor.Hypertension, 1980
- COMBINED TREATMENT OF SEVERE INTRACTABLE HYPERTENSION WITH CAPTOPRIL AND DIURETICThe Lancet, 1980
- Captopril in severe treatment-resistant hypertensionAmerican Heart Journal, 1980
- Captopril in Hypertension with Renal Artery Stenosis and in Intractable Hypertension; Acute and Chronic Changes in Circulating Concentrations of Renin, Angiotensins I and II and Aldosterone, and in Body CompositionClinical Science, 1979
- LONG-TERM EFFECTS OF CAPTOPRIL (SQ14 225) ON BLOOD-PRESSURE AND HORMONE LEVELS IN ESSENTIAL HYPERTENSIONThe Lancet, 1979
- Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive AgentsScience, 1977
- Angiotensin I converting enzyme.Circulation Research, 1975
- THE PREPARATION AND FUNCTION OF THE HYPERTENSIN-CONVERTING ENZYMEThe Journal of Experimental Medicine, 1956